Related Experiment Video
Updated: Feb 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Copeptin in children with chronic kidney disease]
Piotr Skrzypczyk1, Magdalena Okarska-Napierała2, Elżbieta Górska3
1Medical University of Warsaw, Poland: Department of Pediatrics and Nephrology.
Insights
In children with chronic kidney disease (CKD), serum copeptin levels did not differ from healthy children and showed no relation to kidney function. Further research is needed to explore copeptin
Area of Science:
- Pediatric Nephrology
- Biomarker Research
- Chronic Kidney Disease
Background:
- Copeptin, a marker related to kidney and cardiovascular diseases in adults, has not been extensively studied in pediatric populations.
- Understanding copeptin's role in pediatric chronic kidney disease (CKD) is crucial for potential diagnostic and prognostic applications.
Purpose of the Study:
- To investigate serum copeptin concentrations in children diagnosed with chronic kidney disease (CKD).
- To explore potential correlations between copeptin levels and various clinical and biochemical parameters in pediatric CKD patients.
Main Methods:
- A cohort of 38 children with CKD and 38 healthy controls were analyzed for serum copeptin levels.
- Evaluated parameters included age, sex, CKD etiology, arterial hypertension, GFR, hemoglobin, calcium-phosphorus metabolism, and lipids.
Main Results:
- Serum copeptin concentrations were comparable between children with CKD and healthy controls (p=0.088).
- No significant differences in copeptin levels were observed based on sex, arterial hypertension, or CKD stage.
- A positive correlation was found between copeptin and hemoglobin levels in pediatric CKD patients (r=0.35, p=0.031).
Conclusions:
- Copeptin concentration does not appear to be directly related to kidney function in children.
- Copeptin may serve as a potential indicator of hydration status in pediatric patients with CKD.
- Further investigation is warranted to determine the clinical significance of copeptin in pediatric chronic kidney disease.
Abstract:
Studies in adult patients suggest that copeptin (C-terminal fragment of antidiuretin propeptide) is related to kidney and cardiovascular diseases.
Aim:
The aim was to assess copeptin concentration in children with chronic kidney disease (CKD).
Materials And Methods:
In a group of 38 children with CKD (age: from 4.70 to 18.00 mean 12.23±4.19 years) we evaluated: serum copeptin concentration [ng/mL], age, sex, etiology of CKD, presence of arterial hypertension (AH), medications, glomerular filtration rate (GFR), hemoglobin, calcium-phosphorus metabolism parameters, and lipids. Control group consisted of 38 healthy children aged from 5.51 to 18.0 mean 11.79±3.29 years.
Results:
Serum copeptin concentration did not differ between children with CKD and healthy children (0.72±0.34 vs. 0.84±0.33 [ng/mL], p=0.088). In children with CKD there were no differences in copeptin concentration depending on sex, presence of AH, and CKD grade. In children with CKD only positive correlation between copeptin and hemoglobin concentrations was found (r=0.35, p=0.031); no other significant correlations between copeptin and clinical and biochemical parameters including GFR were revealed. Also no significant correlations were found between copeptin and evaluated parameters in the control group.
Conclusions:
In children copeptin concentration does not seem to be related to kidney function. Copeptin may be a marker of hydration status in children with chronic kidney disease. There is a need for further studies evaluating clinical significance of copeptin in children with chronic kidney disease.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

